Editorial: Recent advances in papillary thyroid carcinoma: Progression, treatment and survival predictors.
作者信息
Volpi Erivelto Martinho, Ramirez-Ortega Margarita Carmen, Carrillo Jose Federico
机构信息
Department of Head and Neck, Oswaldo Cruz German Hospital, São Paulo, Brazil.
Centro De Referencia No Ensino Do Diagnóstico Por Imagem (CETRUS), São Paulo, Brazil.
出版信息
Front Endocrinol (Lausanne). 2023 Mar 7;14:1163309. doi: 10.3389/fendo.2023.1163309. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Recent advances in papillary thyroid carcinoma: Progression, treatment and survival predictors.社论：甲状腺乳头状癌的最新进展：进展、治疗及生存预测因素
Front Endocrinol (Lausanne). 2023 Mar 7;14:1163309. doi: 10.3389/fendo.2023.1163309. eCollection 2023.
2
Contemporary evaluation and management of tall cell variant of papillary thyroid carcinoma.当代高细胞型甲状腺乳头状癌的评估与管理。
Curr Opin Endocrinol Diabetes Obes. 2020 Oct;27(5):351-357. doi: 10.1097/MED.0000000000000559.
3
Programmed Death-Ligand 1 (PD-L1) Is a Potential Biomarker of Disease-Free Survival in Papillary Thyroid Carcinoma: a Systematic Review and Meta-Analysis of PD-L1 Immunoexpression in Follicular Epithelial Derived Thyroid Carcinoma.程序性死亡配体 1（PD-L1）是甲状腺乳头状癌无病生存的潜在生物标志物：PD-L1 免疫组化在滤泡上皮来源的甲状腺癌中的系统评价和荟萃分析。
Endocr Pathol. 2020 Sep;31(3):291-300. doi: 10.1007/s12022-020-09630-5.
4
Papillary thyroid carcinoma presenting as a primary renal tumor with multiple pulmonary and bone metastases: a case report.表现为原发性肾肿瘤伴多发肺和骨转移的甲状腺乳头状癌：一例报告
J Med Case Rep. 2019 Apr 20;13(1):95. doi: 10.1186/s13256-019-2025-8.
5
Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.放射性碘对 2 厘米以下侵袭性甲状腺乳头状癌变异型患者的总生存率无改善。
Surgery. 2022 Jan;171(1):203-211. doi: 10.1016/j.surg.2021.05.054. Epub 2021 Aug 10.
6
Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival.低危型甲状腺乳头状癌的早期诊断结果往往是过度治疗而非更好的生存。
Front Endocrinol (Lausanne). 2020 Oct 6;11:571421. doi: 10.3389/fendo.2020.571421. eCollection 2020.
7
High BRAFV600E mutation frequency in Chinese patients with papillary thyroid carcinoma increases diagnostic efficacy in cytologically indeterminate thyroid nodules.中国乳头状甲状腺癌患者中BRAFV600E突变频率较高，提高了甲状腺细针穿刺结果不确定结节的诊断效能。
Medicine (Baltimore). 2019 Jul;98(28):e16343. doi: 10.1097/MD.0000000000016343.
8
Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review.甲状腺乳头状癌-侵袭性变异体及其对管理的影响：叙事性综述。
Adv Ther. 2020 Jul;37(7):3112-3128. doi: 10.1007/s12325-020-01391-1. Epub 2020 Jun 1.
9
[BRAF gene mutation in the natural history of papillary thyroid carcinoma: diagnostic and prognostic implications].[BRAF基因变异在甲状腺乳头状癌自然病程中的诊断及预后意义]
Acta Med Port. 2011 Dec;24 Suppl 4:855-68. Epub 2011 Dec 31.
10
[Relationship and clinical significance between mutated BRAF with prophylactic central-neck nodal dissection in papillary thyroid carcinoma].[BRAF 突变与甲状腺乳头状癌预防性中央区颈淋巴结清扫的关系及临床意义]
Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Jun 18;48(3):502-6.
引用本文的文献
1
Comparison of micro-flow imaging and contrast-enhanced ultrasound in monitoring microwave ablation of papillary thyroid carcinoma: efficacy, safety, and cost-effectiveness.微流成像与超声造影监测甲状腺乳头状癌微波消融的比较：疗效、安全性及成本效益
Front Oncol. 2025 Aug 6;15:1545509. doi: 10.3389/fonc.2025.1545509. eCollection 2025.
2
SPOP-dependent destabilization of SYT12 in a GSK-3β-dependent manner in papillary thyroid cancer cells.在甲状腺乳头状癌细胞中，SPOP以依赖GSK-3β的方式使SYT12不稳定。
Clin Exp Med. 2025 Jul 10;25(1):243. doi: 10.1007/s10238-025-01791-z.
3
Construction and validation of a predictive model for lymph node metastasis in patients with papillary thyroid carcinoma.甲状腺乳头状癌患者淋巴结转移预测模型的构建与验证
Front Endocrinol (Lausanne). 2025 Jun 9;16:1551108. doi: 10.3389/fendo.2025.1551108. eCollection 2025.
4
MAP17 contributes to the tumorigenesis of papillary thyroid carcinoma by activating the AKT signaling pathway.微管相关蛋白17通过激活AKT信号通路促进甲状腺乳头状癌的肿瘤发生。
Arch Endocrinol Metab. 2025 Mar 10;69(1):e240342. doi: 10.20945/2359-4292-2024-0342.
5
Machine Learning and Experiments Revealed Key Genes Related to PANoptosis Linked to Drug Prediction and Immune Landscape in Spinal Cord Injury.机器学习与实验揭示了与脊髓损伤中全程序性坏死相关的关键基因，这些基因与药物预测和免疫格局有关。
Mol Neurobiol. 2025 Jun;62(6):7364-7379. doi: 10.1007/s12035-025-04717-8. Epub 2025 Jan 31.
6
Expression of CLDN1 and EGFR in PTC.CLDN1和EGFR在甲状腺乳头状癌中的表达
Discov Oncol. 2024 Oct 15;15(1):562. doi: 10.1007/s12672-024-01428-9.
7
Risk factors for lateral lymph node metastasis in T1 stage papillary thyroid carcinoma.T1期甲状腺乳头状癌侧方淋巴结转移的危险因素
Gland Surg. 2024 Jun 30;13(6):1152-1153. doi: 10.21037/gs-24-143. Epub 2024 Jun 13.
本文引用的文献
1
BRAFV600E Mutation Enhances Estrogen-Induced Metastatic Potential of Thyroid Cancer by Regulating the Expression of Estrogen Receptors.BRAFV600E 突变通过调节雌激素受体的表达增强甲状腺癌的雌激素诱导转移潜能。
Endocrinol Metab (Seoul). 2022 Dec;37(6):879-890. doi: 10.3803/EnM.2022.1563. Epub 2022 Dec 26.
2
Sonographic Diagnosis of Cervical Lymph Node Metastasis in Patients with Thyroid Cancer and Comparison of European and Korean Guidelines for Stratifying the Risk of Malignant Lymph Node.超声诊断甲状腺癌患者颈部淋巴结转移及比较欧洲和韩国指南对恶性淋巴结风险分层的应用。
Korean J Radiol. 2022 Nov;23(11):1102-1111. doi: 10.3348/kjr.2022.0358. Epub 2022 Sep 16.
3
Predictors of Recurrence in Patients with Papillary Thyroid Carcinoma: Does Male Sex Matter?甲状腺乳头状癌患者复发的预测因素：男性因素有影响吗？
Cancers (Basel). 2022 Apr 9;14(8):1896. doi: 10.3390/cancers14081896.
4
Prophylactic Central Neck Dissection for Clinically Node-Negative Papillary Thyroid Carcinoma.临床淋巴结阴性乳头状甲状腺癌的预防性中央区颈部淋巴结清扫术
Laryngoscope. 2022 Jun;132(6):1320-1328. doi: 10.1002/lary.29912. Epub 2021 Oct 28.
5
A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma.一项前瞻性随机对照试验，旨在评估预防性中央区淋巴结清扫术在甲状腺乳头状癌中的疗效和安全性。
Surgery. 2022 Jan;171(1):182-189. doi: 10.1016/j.surg.2021.03.071. Epub 2021 Aug 12.
6
BRAF and TERT promoter mutations: clinical application in thyroid cancer.BRAF 和 TERT 启动子突变：甲状腺癌的临床应用。
Endocr J. 2020 Jun 29;67(6):577-584. doi: 10.1507/endocrj.EJ20-0063. Epub 2020 Apr 21.
7
Male sex is associated with aggressive behaviour and poor prognosis in Chinese papillary thyroid carcinoma.男性性别与中国甲状腺乳头状癌的侵袭性行为和不良预后相关。
Sci Rep. 2020 Mar 5;10(1):4141. doi: 10.1038/s41598-020-60199-9.
8
Effect of prophylactic central neck dissection on the surgical outcomes in papillary thyroid cancer: experience in a single center.预防性中央区颈部清扫术对甲状腺乳头状癌手术结局的影响：单中心经验。
Eur Arch Otorhinolaryngol. 2020 May;277(5):1491-1497. doi: 10.1007/s00405-020-05830-1. Epub 2020 Feb 12.
9
TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma.TERT 启动子突变鉴定出无转移的晚期甲状腺癌中的高危人群。
Eur J Cancer. 2019 Feb;108:41-49. doi: 10.1016/j.ejca.2018.12.003. Epub 2019 Jan 12.
10
Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.预防性中央区颈淋巴结清扫术在临床淋巴结阴性的乳头状甲状腺癌患者治疗中的临床意义
World J Surg Oncol. 2016 Sep 19;14(1):247. doi: 10.1186/s12957-016-1003-5.
Zotero 插件